Literature DB >> 15197699

Profile of families with parkinsonism-predominant spinocerebellar ataxia type 2 (SCA2).

Sarah Furtado1, Haydeh Payami, Paul J Lockhart, Melissa Hanson, John G Nutt, Andrew A Singleton, Amanda Singleton, Jamel Bower, Ryan J Utti, Thomas D Bird, Raul de la Fuente-Fernandez, Yoshio Tsuboi, Mary L Klimek, Oksana Suchowersky, John Hardy, Donald B Calne, Zbigniew K Wszolek, Matthew Farrer, Katrina Gwinn-Hardy, A Jon Stoessl.   

Abstract

Spinocerebellar ataxia type 2 (SCA2) has been recognized recently as an uncommon cause of parkinsonism, an alternate presentation to the typical cerebellar disorder. This research review summarizes the existing literature on parkinsonism-predominant presentation SCA2 and presents new clinical cases of patients with this condition. Various phenotypes are noted in this subtype of SCA2, including parkinsonism indistinguishable from idiopathic Parkinson's disease (PD), parkinsonism plus ataxia, motor neuron disease, and postural tremor. In several kindreds with multiple affected family members, the SCA2 expansion segregated with disease; in addition, several single cases of parkinsonism with and without a family history are also described. The number of repeats in symptomatic patients ranged from 33 to 43. Interruption of the CAG repeat with CAA, CGG, or CCG was found in some individuals, possibly stabilizing the repeat structure and accounting for the relative stability of the repeat size across generations in some families; allele length is not necessarily indicative of trinucleotide repeat architecture. Positron emission tomography scanning in one family showed reduced fluorodopa uptake and normal to increased raclopride binding with a rostrocaudal gradient similar to that found in idiopathic PD. This review emphasizes the importance of testing for SCA2 in patients with parkinsonism and a family history of neurodegenerative disorders. Testing for SCA2 is also important in studies of inherited parkinsonism. Copyright 2004 Movement Disorder Society

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15197699     DOI: 10.1002/mds.20074

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  29 in total

1.  Coexistence of Huntington's disease and amyotrophic lateral sclerosis: a clinicopathologic study.

Authors:  Mari Tada; Elizabeth A Coon; Alexander P Osmand; Patricia A Kirby; Wayne Martin; Marguerite Wieler; Atsushi Shiga; Hiroe Shirasaki; Masayoshi Tada; Takao Makifuchi; Mitsunori Yamada; Akiyoshi Kakita; Masatoyo Nishizawa; Hitoshi Takahashi; Henry L Paulson
Journal:  Acta Neuropathol       Date:  2012-06-27       Impact factor: 17.088

2.  Cervical dystonia in spinocerebellar ataxia type 2: clinical and polymyographic findings.

Authors:  S M Boesch; J Müller; G K Wenning; W Poewe
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-01-12       Impact factor: 10.154

3.  Jaw-Opening Oromandibular Dystonia Associated With Spinocerebellar Ataxia Type 2.

Authors:  Antonella Antenora; Silvio Peluso; Francesco Saccà; Giuseppe De Michele; Alessandro Filla
Journal:  Mov Disord Clin Pract       Date:  2014-05-26

Review 4.  Vertical supranuclear gaze palsy in Niemann-Pick type C disease.

Authors:  Ettore Salsano; Chizoba Umeh; Alessandra Rufa; Davide Pareyson; David S Zee
Journal:  Neurol Sci       Date:  2012-07-19       Impact factor: 3.307

5.  Ataxin-2 repeat-length variation and neurodegeneration.

Authors:  Owen A Ross; Nicola J Rutherford; Matt Baker; Alexandra I Soto-Ortolaza; Minerva M Carrasquillo; Mariely DeJesus-Hernandez; Jennifer Adamson; Ma Li; Kathryn Volkening; Elizabeth Finger; William W Seeley; Kimmo J Hatanpaa; Catherine Lomen-Hoerth; Andrew Kertesz; Eileen H Bigio; Carol Lippa; Bryan K Woodruff; David S Knopman; Charles L White; Jay A Van Gerpen; James F Meschia; Ian R Mackenzie; Kevin Boylan; Bradley F Boeve; Bruce L Miller; Michael J Strong; Ryan J Uitti; Steven G Younkin; Neill R Graff-Radford; Ronald C Petersen; Zbigniew K Wszolek; Dennis W Dickson; Rosa Rademakers
Journal:  Hum Mol Genet       Date:  2011-05-24       Impact factor: 6.150

6.  Psychotic-affective symptoms and multiple system atrophy expand phenotypes of spinocerebellar ataxia type 2.

Authors:  Kai-Hsiang Chen; Chin-Hsien Lin; Ruey-Meei Wu
Journal:  BMJ Case Rep       Date:  2012-03-20

Review 7.  Roles of trinucleotide-repeat RNA in neurological disease and degeneration.

Authors:  Ling-Bo Li; Nancy M Bonini
Journal:  Trends Neurosci       Date:  2010-04-14       Impact factor: 13.837

8.  Spinocerebellar ataxia type 2 is associated with Parkinsonism and Lewy body pathology.

Authors:  Masaki Takao; Masahiro Aoyama; Kinya Ishikawa; Yoshio Sakiyama; Harumi Yomono; Yuko Saito; Hiroshi Kurisaki; Ban Mihara; Shigeo Murayama
Journal:  BMJ Case Rep       Date:  2011-04-01

Review 9.  Spinocerebellar ataxia type 2: clinical presentation, molecular mechanisms, and therapeutic perspectives.

Authors:  J J Magaña; L Velázquez-Pérez; B Cisneros
Journal:  Mol Neurobiol       Date:  2012-09-21       Impact factor: 5.590

10.  Transcranial sonography in spinocerebellar ataxia type 2.

Authors:  Milija Mijajlović; Natasa Dragasević; Elka Stefanova; Igor Petrović; Marina Svetel; Vladimir S Kostić
Journal:  J Neurol       Date:  2008-05-07       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.